+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication and End User

  • PDF Icon

    Report

  • 108 Pages
  • July 2024
  • Region: Europe
  • The Insight Partners
  • ID: 6006707
UP TO OFF until Dec 31st 2024
The Europe osteoarthritis therapy market was valued at US$ 4.97 billion in 2022 and is expected to reach US$ 8.74 billion by 2030; it is estimated to register a CAGR of 7.3% from 2022 to 2030.

Availability of Regenerative Medicine Drives Europe Osteoarthritis Therapy Market

Regenerative medicine is a new and potentially transformative alternative to traditional therapy options to treat OA. Regenerative medicine utilizes biomedical engineering, biomaterials, and cell therapies that target the body's immune system to treat OA. Also, clinical researchers have developed methods to fix the articular cartilage of patients using patients' (autologous) cells. Further, regenerative therapy options use "Matrix-Induced Autologous Chondrocyte Implantation (MACI)." MACI can repair small areas of cartilage, ultimately preventing or postponing OA. Also, several manufacturers are developing products focused on regenerative therapy.

Rising inclination toward non-surgical approaches such as PRP therapy, stem cell therapy, hyaluronic acid injections, and prolotherapy would propel the adoption of regenerative medicine. Patients suffering from OA can be treated using non-pharmacological therapies. Regenerative therapy options can improve joint functions by ultimately reducing pain and enhancing the overall quality of life for individuals suffering from OA. Therefore, increasing adoption of regenerative medicine is expected to open new business opportunities in the osteoarthritis therapy market during the forecast period.

Europe Osteoarthritis Therapy Market Overview

Europe osteoarthritis therapy market is segmented as Germany, the UK, France, Italy, Spain, and the Rest of Europe. Fast product approvals in the region for osteoarthritis treatment drugs and advanced healthcare infrastructure are the most influential factors responsible for market growth. According to the Journal of Health Monitoring report, osteoarthritis is the most common joint disease in Germany. Joint pain and loss of function are likely to result in loss of quality of life as osteoarthritis is caused in the upper extremities (fingers, hands, and shoulders). Therefore, with the aging of Germany's population, osteoarthritis prevalence will continue to rise, resulting in a high burden on the healthcare system.

According to the World Health Organization (WHO) report published in 2020, osteoarthritis deaths in Germany account for 0.05% of total deaths. Further, new product launches enhance the market growth. For instance, in May 2023, Grünenthal announced receiving approval for investigational non-opioid medicine "Resiniferatoxin (RTX)," currently undergoing Clinical Phase 3 development standing as a breakthrough therapy by the US Food and Drug Administration (USFDA) to treat knee OA. Resiniferatoxin can become a meaningful non-opioid treatment option, providing long-lasting pain relief and functional improvement of the affected joint.

Europe Osteoarthritis Therapy Market Segmentation

The Europe osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.
  • Based on therapy type, the Europe osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.
  • In terms of disease indications, the Europe osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Europe osteoarthritis therapy market in 2022.
  • Based on end users, the Europe osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Europe osteoarthritis therapy market in 2022.
  • By country, the Europe osteoarthritis therapy market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe osteoarthritis therapy market share in 2022.
Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, and Medi GmbH & Co KG are some of the leading companies operating in the Europe osteoarthritis therapy market.

Table of Contents

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. Europe Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - Europe Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. Europe Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Osteoarthritis Therapy Market - Country Analysis
10.1 Europe Market Overview
10.1.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 Zimmer Biomet Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DePuy Synthes Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bioventus Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Omron Healthcare Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Exactech Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Medi GmbH & Co KG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Publisher
LIST OF TABLES
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
LIST OF FIGURES
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 26. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. Growth Strategies in the Osteoarthritis Therapy market

Companies Mentioned

  • Zimmer Biomet Holdings Inc
  • DePuy Synthes Inc
  • Bioventus Inc
  • Omron Healthcare Inc
  • Exactech Inc
  • Medi GmbH & Co KG